Stathmin 1 expression in neuroendocrine and proliferating prostate cancer
Abstract Prostate cancer (PCa) is the second leading cause of cancer-related mortality among men in the United States. While PCa initially responds to androgen deprivation therapy, a significant portion progresses to castration-resistant PCa. Approximately 20–25% of these cases acquire aggressive ne...
Saved in:
Main Authors: | Yingli Shi, Yunshin A. Yeh, Siyuan Cheng, Xin Gu, Shu Yang, Lin Li, Nazih P. Khater, Susan Kasper, Xiuping Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2025-01-01
|
Series: | Discover Oncology |
Online Access: | https://doi.org/10.1007/s12672-025-01754-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Distribution of Neuroendocrine Cells in the Transition Zone of the Prostate
by: Yuki Kyoda, et al.
Published: (2017-01-01) -
Leptin Regulates Proliferation and Apoptosis in Human Prostate
by: Eduardo Leze, et al.
Published: (2012-01-01) -
Polypeptide Expression in Prostate Hyperplasia and Prostate Adenocarcinoma
by: Ayodele Alaiya, et al.
Published: (2000-01-01) -
Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors
by: Mario Orozco-Morales, et al.
Published: (2021-01-01) -
Co-modulation of a circular form of PCDH11Y during neuroendocrine differentiation of prostate cancer
by: Giovanni Pecoraro, et al.
Published: (2025-02-01)